
StemRIM Inc. — Investor Relations & Filings
StemRIM Inc. is a biotechnology company developing a next-generation category of regenerative medicine called “Regeneration-Inducing Medicine™”. This innovative approach aims to treat intractable diseases and injuries by maximizing the body's innate tissue repair capabilities. The core mechanism of action involves mobilizing a patient's own endogenous stem cells to damaged tissues to induce functional regeneration, a method distinct from conventional cell-therapy. The company's research and development focuses on creating new drugs based on this novel mechanism, with applications including gene therapy for rare skin diseases such as dystrophic epidermolysis bullosa.
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
7 filings
| |||||
| 7544359 | 臨時報告書 | 2023-09-20 | Japanese | ||
| 7544358 | 臨時報告書 | 2023-09-20 | Japanese | ||
| 7552548 | 臨時報告書 | 2023-07-26 | Japanese | ||
| 7565975 | 確認書 | 2023-06-14 | Japanese | ||
| 7565977 | 四半期報告書-第18期第3四半期(2023/02/01-2023/04/30) | 2023-06-14 | Japanese | ||
| 7572477 | 確認書 | 2023-03-09 | Japanese | ||
| 7572478 | 四半期報告書-第18期第2四半期(2022/11/01-2023/01/31) | 2023-03-09 | Japanese | ||
|
2022
7 filings
| |||||
| 7580489 | 確認書 | 2022-12-15 | Japanese | ||
| 7580490 | 四半期報告書-第18期第1四半期(令和4年8月1日-令和4年10月31日) | 2022-12-15 | Japanese | ||
| 7587658 | 内部統制報告書-第17期(令和3年8月1日-令和4年7月31日) | 2022-10-27 | Japanese | ||
| 7587657 | 確認書 | 2022-10-27 | Japanese | ||
| 7587660 | 有価証券報告書-第17期(令和3年8月1日-令和4年7月31日) | 2022-10-27 | Japanese | ||
| 7605575 | 四半期報告書-第17期第3四半期(令和4年2月1日-令和4年4月30日) | 2022-06-10 | Japanese | ||
| 7615009 | 四半期報告書-第17期第2四半期(令和3年11月1日-令和4年1月31日) | 2022-03-11 | Japanese | ||
|
2021
1 filing
| |||||
| 7620295 | 四半期報告書-第17期第1四半期(令和3年8月1日-令和3年10月31日) | 2021-12-10 | Japanese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
StemRIM Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/14224/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=14224 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=14224 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=14224 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 14224}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for StemRIM Inc. (id: 14224)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.